1. Home
  2. DAIO vs SNTI Comparison

DAIO vs SNTI Comparison

Compare DAIO & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

HOLD

Current Price

$2.69

Market Cap

22.3M

Sector

Industrials

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$0.95

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAIO
SNTI
Founded
1969
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3M
24.5M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
DAIO
SNTI
Price
$2.69
$0.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$5.22
$8.50
AVG Volume (30 Days)
50.5K
141.1K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.31
EPS
N/A
N/A
Revenue
$21,500,000.00
N/A
Revenue This Year
$4.51
N/A
Revenue Next Year
$30.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.16
$0.77
52 Week High
$3.49
$3.88

Technical Indicators

Market Signals
Indicator
DAIO
SNTI
Relative Strength Index (RSI) 58.30 48.67
Support Level $2.59 $0.78
Resistance Level $2.76 $0.99
Average True Range (ATR) 0.18 0.08
MACD 0.04 0.01
Stochastic Oscillator 87.60 34.19

Price Performance

Historical Comparison
DAIO
SNTI

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: